Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C18H19NO5 |
| Molecular Weight | 329.3472 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=C(O)C=CC(\C=C\C(=O)NCCC2=CC=C(O)C(O)=C2)=C1
InChI
InChIKey=ZRLYUFOWFPPSTD-QPJJXVBHSA-N
InChI=1S/C18H19NO5/c1-24-17-11-12(3-6-15(17)21)4-7-18(23)19-9-8-13-2-5-14(20)16(22)10-13/h2-7,10-11,20-22H,8-9H2,1H3,(H,19,23)/b7-4+
| Molecular Formula | C18H19NO5 |
| Molecular Weight | 329.3472 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Optical Activity | NONE |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 21:02:48 GMT 2025
by
admin
on
Mon Mar 31 21:02:48 GMT 2025
|
| Record UNII |
NGL0OTK5E8
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID70162023
Created by
admin on Mon Mar 31 21:02:48 GMT 2025 , Edited by admin on Mon Mar 31 21:02:48 GMT 2025
|
PRIMARY | |||
|
NGL0OTK5E8
Created by
admin on Mon Mar 31 21:02:48 GMT 2025 , Edited by admin on Mon Mar 31 21:02:48 GMT 2025
|
PRIMARY | |||
|
16119330
Created by
admin on Mon Mar 31 21:02:48 GMT 2025 , Edited by admin on Mon Mar 31 21:02:48 GMT 2025
|
PRIMARY | |||
|
142350-99-0
Created by
admin on Mon Mar 31 21:02:48 GMT 2025 , Edited by admin on Mon Mar 31 21:02:48 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
440 uM IC50 vs in vitro prostaglandin synthesis
|
||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
Among the compounds tested in this study, N-coumaroyldopamine and N-caffeoyldopamine were the two most potent compounds, able to increase cAMP at the concentrations < 0.05 uM in U937 cells. The decreasing order of potency was N-coumaroyldopamine > N- affeoyldopamine > N-feruloyldopamine > N-sinapoyldopamine > N-cinnamoyldopamine.
|
